Vicore Pharma Holding AB (SE0007577895) — research page
SE · se-cm-kg/XSTO/SE0007577895 · as of 2026-11-06
Identity and listing
The issuer is Vicore Pharma Holding AB, listed on Nasdaq Stockholm under ticker SE0007577895 with ISIN SE0007577895 and LEI 549300KTNBPTZLF01130. Its security type, segment, sector and jurisdiction are not on the record. Its listing status is listed, not halted.
| field | value | source · read date |
|---|---|---|
| name | Vicore Pharma Holding AB | source · 2026-11-06 |
| exchange | Nasdaq Stockholm | source · 2026-11-06 |
| ticker | SE0007577895 | source · 2026-11-06 |
| ISIN | SE0007577895 | source · 2026-11-06 |
| LEI | 549300KTNBPTZLF01130 | source · 2026-11-09 |
| security type | not on the record | |
| segment | not on the record | |
| sector | not on the record | |
| jurisdiction | not on the record | |
| status | listed, not halted | source · 2026-11-09 |
The disclosure read
The record holds 37 filings across 36 filing days in the twelve months to 2026-11-06. The median gap between filing days is 7 days. The latest filing is dated 2026-11-05 and is of type Interim report (Q1 and Q3), 1 day before the record date. Nasdaq Stockholm holds 398 issuers with a median of 30.0 filings, a median cadence gap of 9.5 days and a median latency of 7.0 days. The issuer's 37 filings are above that median, its cadence gap of 7 days is below it, and its latency of 1 day is below it. The sector median is not on the record.
| filings | median gap between filing days | days from latest filing to as-of | |
|---|---|---|---|
| this issuer | 37 | 7 | 1 |
| exchange median: Nasdaq Stockholm (398 issuers) | 30 | 9.5 | 7 |
| date | type | category | filing |
|---|---|---|---|
| 2026-11-05 | Interim report (Q1 and Q3) | Interim report (Q1 and Q3) | Vicore Pharma Announces Third Quarter 2026 Financial Results and Provides Business Update |
| 2026-11-03 | Other information disclosed according to the rules of the Exchange | Other information disclosed according to the rules of the Exchange | Vicore Announces the Nomination Committee for the 2027 Annual General Meeting |
| 2026-11-02 | Investor News | Investor News | Vicore Pharma to Participate in the Guggenheim Annual Healthcare Innovation Conference and the Stifel Healthcare Conference |
| 2026-10-22 | Inside information | Inside information | Vicore's Phase 2b ASPIRE Trial of Buloxibutid in IPF Passes Pre-Planned Futility Analysis and Remains on Track for Mid-2027 Topline Results |
| 2026-10-13 | Investor News | Investor News | Vicore Pharma to Participate in the Chardan Healthcare Conference |
window 2025-11-06 to 2026-11-06 · the node's disclosure lines, as get_filings serves them
Auditor
The auditor of record is not on the record, nor is its location. Auditor changes are not on the record, as the market's record does not carry them.
Events and halts
The record does not carry listing, delisting, name change, domicile change or segment move events, as no lifecycle type map exists for this register. The halt flag reads listed, not halted.
Orderability
The outcome is not determinable because the chapter's orderability section carries no client categories. The rule version is acm-68000/se/mifid-ii-product-governance/r1, and the chapter is as of 2026-11-04.
rule acm-68000/se/mifid-ii-product-governance/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability
Coverage
The issuer's investor-relations page names 11 research houses: ABG Sundal Collier, Cantor, Danske Bank, DNB Carnegie, Guggenheim, Jefferies, Pareto Securities, Stifel, Van Lanschot Kempen, Arctic Securities and Chardan.
| research house | analyst | source · read date |
|---|---|---|
| ABG Sundal Collier | Georg Tigalonov-Bjerke | issuer page · 2026-11-12 |
| Cantor | Steve Seedhouse | issuer page · 2026-11-12 |
| Danske Bank | Gonzalo Artiach | issuer page · 2026-11-12 |
| DNB Carnegie | Arvid Necander | issuer page · 2026-11-12 |
| Guggenheim | Vamil Divan | issuer page · 2026-11-12 |
| Jefferies | Faisal Khurshid | issuer page · 2026-11-12 |
| Pareto Securities | Chien-Hsun Lee | issuer page · 2026-11-12 |
| Stifel | Clemence Thiers | issuer page · 2026-11-12 |
| Van Lanschot Kempen | Sushila Hernandez | issuer page · 2026-11-12 |
| Arctic Securities | issuer page · 2026-11-12 | |
| Chardan | issuer page · 2026-11-12 |
Open research
The record holds 1 openly published research note, by goetzpartners securities Limited, dated 2018-03-22.
| date | publisher | note | kind |
|---|---|---|---|
| 2018-03-22 | goetzpartners securities Limited | Novel approach to tackle fibrotic orphan diseases | issuer-sponsored |
Licensed
Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.
| licensor | entitlement | title | date | source |
|---|---|---|---|---|
| none loaded |
As-of depth
No issuer years are sealed. The market's vintage is not sealed, so no earliest sealed date is given and the live record's start is not on the record.
Sources
8 source pages are named on this page; every value above carries its own source page and read date in the numbers.
- 10.1
- https://firds.esma.europa.eu/firds/ (identity.exchange)
- 10.2
- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)
- 10.3
- https://mcp.se-cm-kg.ai/events/XSTO/SE0007577895 (the disclosure lines)
- 10.4
- https://api.news.eu.nasdaq.com/news/query.action?globalGroup=exchangeNotice&globalName=ExchangenewsFilter|FirstNorthInformation (the halt flag)
- 10.5
- https://se.eu-cm-kg.ai/book/aio.json (the orderability chapter)
- 10.6
- https://vicorepharma.com/investerare/aktieinformation-2/analytiker/ (coverage)
- 10.7
- http://vicorepharma.com/wp-content/uploads/2019/06/goetz-partners-vph-180322.pdf (open research)
- 10.8
- https://mcp.se-cm-kg.ai/record/XSTO/SE0007577895 (the record)
Read it by agent
The same page, signed and receipted: get_research at https://mcp.getresearch.ai/mcp with {"isin":"SE0007577895"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:f37a1601e30963bd.